Kathy P. Ordonez's most recent trade in Pacific Biosciences of California Inc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 32,179 | 32,179 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 22,821 | 403,037 (0%) | 0% | 0 | Common Stock | |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 324,515 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 15 Mar 2024 | 324,515 | 343,110 (0%) | 0% | 2.9 | 941,094 | Common Stock |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 37,106 | 0 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 15 Mar 2024 | 37,106 | 380,216 (0%) | 0% | 2.6 | 97,589 | Common Stock |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Sale of securities on an exchange or to another person at price $ 11.50 per share. | 16 Feb 2022 | 3,280 | 18,595 (0%) | 0% | 11.5 | 37,720 | Common Stock |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,885 | 12,885 | - | - | Stock Option (right to buy) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 1,624 | 1,624 | - | - | Restricted Stock Units (Equity Grant) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 427 | 427 | - | - | Restricted Stock Units (Converted) | |
| QuidelOrtho Corporation | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 42 | 42 | - | - | Restricted Stock Units (Premium) |